AGP Executive Report
Last update: 4 hours agoUS–EU Pharma Clash: The U.S. has opened a Section 301 trade probe into Germany’s drug-pricing reforms, alleging “persistent underpayment” for innovative medicines—raising the risk of new tariffs and widening the fight from health policy into trade policy. EU China Supply-Chain Pressure: Brussels is moving from voluntary “de-risking” toward possible legal duties for companies to diversify critical supply chains, as China export restrictions and Europe’s dependence on strategic inputs sharpen the industrial and security stakes. Auto Industry Cost Squeeze: Porsche is in the final stages of a second cost-cutting package, aiming to deliver clarity to employees before July factory holidays, as weaker China demand and tariff pressure erode profits. Energy Tech Showcase: WattCycle is debuting an all-in-one balcony solar storage system at Intersolar Europe 2026, pitching AI-managed energy control for higher self-consumption. Defense Procurement Workaround: After the U.S. declined to station Tomahawk missiles in Germany, Berlin is reportedly approaching Ukrainian and Israeli firms for alternative long-range cruise options. Crypto Regulation Milestone: Italy’s Conio has secured an EU MiCA crypto-asset service provider license, one of the last authorizations before the June 30 cut-off. World Cup Business Angle: Germany’s match logistics and travel screening are drawing attention as the team heads to Toronto for the Germany–Ivory Coast game.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.